Investigate The Efficacy Of Immunotherapy For Treatment Of Pancreatic Adenocarcinoma (Pdac) With Mismatch Repair Deficiency (Dmmr).

Arish Noor,Luis E. Aguirre,Kirsten Blue,Trenton Avriett,Estrella M. Carballido,Richard D. Kim,Dae Won Kim

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 4|浏览1

暂无评分

摘要

415Background: Immune checkpoint inhibitors (ICI) have been approved in solid tumors with dMMR. However, only limited data are available for PDAC with dMMR given the rarity of dMMR in PDAC. We eval...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要